Tomocube Past Earnings Performance
Past criteria checks 0/6
Tomocube's earnings have been declining at an average annual rate of -17.1%, while the Medical Equipment industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 81.9% per year.
Key information
-17.1%
Earnings growth rate
13.5%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 81.9% |
Return on equity | -163.2% |
Net Margin | -445.5% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How Tomocube makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 5,096 | -22,700 | 5,207 | 5,107 |
31 Mar 24 | 4,421 | -23,125 | 4,911 | 4,388 |
31 Dec 23 | 3,747 | -23,550 | 4,615 | 3,668 |
31 Dec 22 | 1,871 | 29,336 | 3,701 | 3,243 |
31 Dec 21 | 1,625 | -19,349 | 2,976 | 3,773 |
31 Dec 20 | 858 | -11,256 | 2,360 | 3,051 |
Quality Earnings: A475960 is currently unprofitable.
Growing Profit Margin: A475960 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A475960 is unprofitable, and losses have increased over the past 5 years at a rate of 17.1% per year.
Accelerating Growth: Unable to compare A475960's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A475960 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.6%).
Return on Equity
High ROE: A475960 has a negative Return on Equity (-163.2%), as it is currently unprofitable.